Replimune (REPL) Non Operating Interest Expenses (2019 - 2026)
Replimune's Non Operating Interest Expenses was $2.52 million in fiscal Q2 2027 (quarter ended Sep 30, 2026), up 69.6% from $1.49 million a year earlier but down 2.2% from the prior quarter.
Replimune (REPL) Non Operating Interest Expenses (2019 - 2026) Analysis & Trends
On a trailing twelve-month basis, Replimune's Non Operating Interest Expenses was $8.94 million through Sep 30, 2026, up 52.1% year-over-year; for FY2026 (ended Mar 31, 2026), it came in at $6.8 million, up 17.7% from FY2025.
- Non Operating Interest Expenses has now increased for three consecutive fiscal years, with a five-year compound annual growth rate of 52.7% (FY2021 to FY2026).
- In earlier fiscal years, Non Operating Interest Expenses was $5.78 million in FY2025 (+28.4%), $4.5 million in FY2024 (+129.1%) and $1.96 million in FY2023.
- Quarterly Non Operating Interest Expenses has moved between $941,000 (fiscal Q3 2023) and $2.58 million (fiscal Q1 2027) over five years.
- Compared with a year earlier, Non Operating Interest Expenses has increased for 12 straight quarters, with growth averaging 32.6% over the last eight quarters.
- The year-over-year growth in Non Operating Interest Expenses has ranged between 1.1% (fiscal Q3 2026) and 75.0% (fiscal Q1 2027) over the last five years.
- Per Business Quant data, REPL's Non Operating Interest Expenses in the three fiscal quarters before Q2 2027 was $2.58 million (Q1 2027), $2.37 million (Q4 2026) and $1.47 million (Q3 2026).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Interest Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 217.00 Mn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | - |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | - |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 462.00 Mn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | 435.00 Mn |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 653.00 Mn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 269.00 Mn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | - |
| 10 | Replimune | 2.40 Bn | 1.35 Bn | - | 2.52 Mn |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 2.52 Mn |
| Jun 30, 2026 | 2.58 Mn |
| Mar 31, 2026 | 2.37 Mn |
| Dec 31, 2025 | 1.47 Mn |
| Sep 30, 2025 | 1.49 Mn |
| Jun 30, 2025 | 1.48 Mn |
| Mar 31, 2025 | 1.46 Mn |
| Dec 31, 2024 | 1.45 Mn |
| Sep 30, 2024 | 1.44 Mn |
| Jun 30, 2024 | 1.43 Mn |
| Mar 31, 2024 | 1.41 Mn |
| Dec 31, 2023 | 1.01 Mn |
| Sep 30, 2023 | 955,000.00 |
| Jun 30, 2023 | 1.12 Mn |
| Mar 31, 2023 | 1.02 Mn |
| Dec 31, 2022 | 941,000.00 |
| Mar 31, 2021 | 1,000.00 |
| Dec 31, 2020 | 247,000.00 |
| Sep 30, 2020 | 286,000.00 |
| Jun 30, 2020 | 284,000.00 |
Replimune Non Operating Interest Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=REPL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-interest-expenses", "ticker": "REPL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=REPL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();